Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,330,696    

Indirect Value

   $12,970,625,176      
Total Shares   142,789,105      
Total Value   $13,052,955,872      


Incyte Corp $32,797,033 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $316,227 Neurogene $16,634 Incyte Corp $32,797,033 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $316,227 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 50 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2011-05-27 4 B $27.04 $1,491,922 I/I 55,183 5,729,287 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2009-02-06 4 S $8.17 $6,148,420 I/I (752,204) 5,771,961 0 -
GHDX Genomic Health Inc Director   –       •       •   2011-05-31 4 B $27.46 $1,512,235 I/I 55,039 5,784,326 2.25 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-05-25 4 B $1.60 $109,558 I/I 68,534 5,784,851 1.5 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-05-26 4 B $1.59 $102,196 I/I 64,420 5,849,271 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-01 4 B $27.47 $1,964,575 I/I 71,471 5,855,797 2.25 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-05-27 4 B $1.60 $71,640 I/I 44,862 5,894,133 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-07 4 B $26.14 $1,810,136 I/I 69,198 5,924,995 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-08 4 B $26.10 $1,164,432 I/I 44,563 5,969,558 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-21 4 S $5.55 $342,460 I/I (61,690) 6,011,855 0 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-09 4 B $26.25 $2,360,109 I/I 89,891 6,059,449 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-30 4 A $0.00 $0 I/I 7,280 6,066,729 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-19 4 S $5.64 $4,297,713 I/I (755,352) 6,073,545 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $478,630 I/I 69,943 6,081,798 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-03 4 B $24.42 $519,553 I/I 21,221 6,087,950 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-04 4 B $25.78 $1,441,461 I/I 55,920 6,143,870 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-08 4 B $7.21 $994,457 I/I 137,895 6,219,693 1.5 -
VPHM Viropharma Inc 10% Owner   –       –       •   2009-05-07 4 B $5.72 $1,250,143 I/I 218,471 6,258,146 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-09 4 B $6.96 $299,449 I/I 43,023 6,262,716 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-07 4 B $26.20 $3,474,033 I/I 132,371 6,276,241 2.25 -
INCY Incyte Corp Director   –       •       •   2008-07-31 4 B $9.00 $7,776,828 I/I 864,092 6,291,968 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-10 4 B $7.47 $596,348 I/I 79,841 6,342,557 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-09 4 B $26.66 $1,941,654 I/I 72,479 6,348,720 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-11 4 B $7.47 $283,387 I/I 37,921 6,380,478 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-10 4 B $26.89 $993,654 I/I 36,956 6,385,676 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50  51   52   53   54   55   56      
  Page 50 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us